Private Equity
Morpheus Ventures is seeking to raise $200 million for its second fund, according to an SEC filing. The Sherman Oaks, California-based venture firm targets early-stage tech firms.
1 min read · 29 July 2019
Vistara Capital Partners held the second close of its third technology debt fund, bringing the total raised to more than $100 million (US$75 million). Vistara Technology Growth Fund III, launched last October with a target of $130 million, is expected to reach its goal later this year, Managing Partner Randy Garg and Partner Noah Shipman told PE Hub Canada. The second close was anchored by two new institutions: the investment program of federal agency Export Development Canada and Nicola Wealth, a Canadian wealth management firm. Fund III will maintain Vistara’s strategy of providing flexible debt and equity financing for North American mid- to late-stage companies looking to fuel growth without diluting ownership.
3 min read · 29 July 2019
3 min read · 26 July 2019
1 min read · 26 July 2019
3 min read · 26 July 2019
2 min read · 26 July 2019
3 min read · 26 July 2019
Camber Creek has hired Mitchell Schear as a general partner. He is the former president of Vornado/Charles E. Smith.
3 min read · 25 July 2019
OSF Ventures has raised $75 million for its second venture fund. The fund will invest in new technology, devices and services that offer improved and more cost efficient health care.
3 min read · 25 July 2019
Salt Lake City-based Health Catalyst, a provider of data and analytics technology and services to healthcare organizations, has raised $182 million for its IPO after pricing its 7 million shares at $26 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "HCAT." Goldman Sachs, J.P. Morgan and William Blair are the lead underwriters. Health Catalyst's pre-IPO backers included OrbiMed, Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures.
3 min read · 25 July 2019
